NL8303211A - Nieuwe farmaceutische preparaten op basis van cisplatinum en werkwijze voor het bereiden daarvan. - Google Patents

Nieuwe farmaceutische preparaten op basis van cisplatinum en werkwijze voor het bereiden daarvan. Download PDF

Info

Publication number
NL8303211A
NL8303211A NL8303211A NL8303211A NL8303211A NL 8303211 A NL8303211 A NL 8303211A NL 8303211 A NL8303211 A NL 8303211A NL 8303211 A NL8303211 A NL 8303211A NL 8303211 A NL8303211 A NL 8303211A
Authority
NL
Netherlands
Prior art keywords
cisplatinum
sterile
lyophilized
product
stable
Prior art date
Application number
NL8303211A
Other languages
English (en)
Dutch (nl)
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of NL8303211A publication Critical patent/NL8303211A/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8303211A 1982-09-23 1983-09-16 Nieuwe farmaceutische preparaten op basis van cisplatinum en werkwijze voor het bereiden daarvan. NL8303211A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT23396/82A IT1153974B (it) 1982-09-23 1982-09-23 Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
IT2339682 1982-09-23

Publications (1)

Publication Number Publication Date
NL8303211A true NL8303211A (nl) 1984-04-16

Family

ID=11206716

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8303211A NL8303211A (nl) 1982-09-23 1983-09-16 Nieuwe farmaceutische preparaten op basis van cisplatinum en werkwijze voor het bereiden daarvan.

Country Status (20)

Country Link
US (1) US4670262A (fr)
JP (1) JPS5978117A (fr)
AT (1) AT382077B (fr)
AU (1) AU559499B2 (fr)
BE (1) BE897761A (fr)
CA (1) CA1211372A (fr)
CH (1) CH655852A5 (fr)
DE (1) DE3333024A1 (fr)
DK (1) DK157168C (fr)
FI (1) FI78236C (fr)
FR (1) FR2533439B1 (fr)
GB (1) GB2127291B (fr)
GR (1) GR79055B (fr)
IE (1) IE56173B1 (fr)
IL (1) IL69752A (fr)
IT (1) IT1153974B (fr)
NL (1) NL8303211A (fr)
SE (1) SE464061B (fr)
SU (1) SU1424722A3 (fr)
ZA (1) ZA836904B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
ES8801168A1 (es) * 1984-11-02 1987-02-16 Johnson Matthey Plc Procedimiento para la obtencion de un compuesto de platino para utilizar en quimioterapia del cancer.
JPH0665648B2 (ja) * 1985-09-25 1994-08-24 塩野義製薬株式会社 白金系抗癌物質の安定な凍結真空乾燥製剤
JP2524217B2 (ja) * 1988-04-18 1996-08-14 マルハ株式会社 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤または痴呆治療剤
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
US20030148933A1 (en) * 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
JPH06192109A (ja) * 1992-09-04 1994-07-12 Fuji Kagaku Kogyo Kk 抗腫瘍効果増強剤
FR2759293B1 (fr) * 1997-02-11 1999-04-30 Ethypharm Lab Prod Ethiques Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
GB9803448D0 (en) * 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
ATE363910T1 (de) * 1999-11-15 2007-06-15 Pharma Mar Sa Behandlung von krebserkrankungen durch aplidin
UA76718C2 (uk) * 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
KR20030038812A (ko) * 2000-10-12 2003-05-16 파르마 마르, 에스.에이. 암 치료 방법
CA2435146C (fr) 2001-01-25 2011-03-29 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Formulation de composes d'acide boronique
JP4272991B2 (ja) * 2001-09-21 2009-06-03 大日本住友製薬株式会社 凍結乾燥製剤
CA2462642A1 (fr) * 2001-10-19 2003-04-24 Pharma Mar, S.A. Utilisation d'aplidine pour le traitement du cancer du pancreas
KR101160320B1 (ko) * 2003-03-12 2012-06-26 파르마 마르 에스.에이. 다발 골수종 치료를 위한 아플리딘
NZ541634A (en) * 2003-03-12 2008-08-29 Pharma Mar Sa Improved antitumoral treatments
DK1523984T3 (da) * 2003-10-13 2007-03-26 Zoser B Salama Farmaceutisk sammensætning indeholdende oxoplatin og dettes salte
US8436190B2 (en) 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
DK2029155T3 (en) * 2006-02-28 2016-08-01 Pharma Mar Sa IMPROVED treatment of multiple myeloma
AU2008313627A1 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Improved antitumoral treatments
AU2009221720A1 (en) * 2008-03-07 2009-09-11 Pharma Mar, S.A. Improved anticancer treatments
AR072777A1 (es) 2008-03-26 2010-09-22 Cephalon Inc Formas solidas de clorhidrato de bendamustina
EP2889029A1 (fr) * 2008-09-25 2015-07-01 Cephalon, Inc. Formulations liquides de bendamustine
CN107773538B (zh) * 2016-08-27 2022-09-13 鲁南制药集团股份有限公司 稳定的甲啶铂无菌冻干粉末及其制备工艺
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1432562A (en) * 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum co-ordination compounds
GB1432563A (en) * 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum- co-ordination compounds
US4053587A (en) * 1973-04-13 1977-10-11 Research Corporation Method of treating viral infections
US4255417A (en) * 1976-08-04 1981-03-10 Johnson Matthey, Inc. Platinum compounds for the irradication of skin blemishes
CA1119954A (fr) * 1978-05-30 1982-03-16 Edmund S. Granatek Solution aqueuse de cisplatine
US4273755A (en) * 1979-08-16 1981-06-16 Mpd Technology Corporation Preparation of platinum complexes
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
US4451447A (en) * 1980-03-31 1984-05-29 Bristol-Myers Company Pharmaceutical formulations
CA1162479A (fr) * 1980-03-31 1984-02-21 Murray A. Kaplan Compose pharmaceutique contenant du cisplatine

Also Published As

Publication number Publication date
GB2127291B (en) 1986-01-15
IL69752A0 (en) 1983-12-30
JPS5978117A (ja) 1984-05-04
DK157168B (da) 1989-11-20
AU559499B2 (en) 1987-03-12
ZA836904B (en) 1984-10-31
DE3333024A1 (de) 1984-03-29
IT8223396A0 (it) 1982-09-23
IE56173B1 (en) 1991-05-08
FR2533439A1 (fr) 1984-03-30
DK424383A (da) 1984-03-24
SE8304920L (sv) 1984-03-24
AT382077B (de) 1987-01-12
FI833300A (fi) 1984-03-24
IL69752A (en) 1986-07-31
GB8324380D0 (en) 1983-10-12
FI78236C (fi) 1989-07-10
AU1908983A (en) 1984-03-29
CH655852A5 (de) 1986-05-30
FR2533439B1 (fr) 1986-08-14
BE897761A (fr) 1984-01-02
IE832172L (en) 1984-03-23
SE464061B (sv) 1991-03-04
GR79055B (fr) 1984-10-02
DK424383D0 (da) 1983-09-16
FI78236B (fi) 1989-03-31
IT1153974B (it) 1987-01-21
ATA326283A (de) 1986-06-15
FI833300A0 (fi) 1983-09-15
SU1424722A3 (ru) 1988-09-15
US4670262A (en) 1987-06-02
DK157168C (da) 1990-04-09
CA1211372A (fr) 1986-09-16
GB2127291A (en) 1984-04-11
SE8304920D0 (sv) 1983-09-13

Similar Documents

Publication Publication Date Title
NL8303211A (nl) Nieuwe farmaceutische preparaten op basis van cisplatinum en werkwijze voor het bereiden daarvan.
JPH0313174B2 (fr)
CZ298581B6 (cs) Farmaceuticky stabilní prípravek oxaliplatiny k parenterální aplikaci
EP2887953B1 (fr) Formulation injectable améliorée de daptomycine
RU2362557C2 (ru) Фармацевтическая композиция винфлунина, предназначенная для парентерального введения, способ получения и применение
NL7909199A (nl) Farmaceutisch preparaat voor het behandelen van nieuw- vormingsziekten en werkwijzen voor het bereiden ervan.
CN101991857B (zh) 稳定型药物制剂及其制备方法
CS246051B2 (en) Cis-platinum-diaminodichloride's stable concentrated solution production method
KR101487953B1 (ko) 유기용매 무함유 젬시타빈 수용액 조성물
CN1269487C (zh) 三氧化二砷口服液及其生产方法
JPS5938207B2 (ja) 腎疾患治療剤
JPS61197527A (ja) インタ−ロイキン−2組成物
CN1074278C (zh) 前列腺素e1无菌冻干粉针剂生产工艺
RU2096043C1 (ru) Антигипоксическое средство и способ его получения
RU2680804C1 (ru) Стабильное средство лечения болезней суставов
KR20070067768A (ko) 안정한 옥살리플라틴 조성물 및 이의 제조방법
JP2018123114A (ja) ダルベポエチンを含む液体医薬組成物
Hrubiško et al. Suitability of cisplatin solutions for 14-day continuous infusion by ambulatory pump
JP2770571B2 (ja) 安定化された注射剤および注射剤の安定化法
EP1691813B1 (fr) Solution injectable prete a l'emploi, sterile, stable, de 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one; systeme ferme permettant de conditionner la solution, procede d'elimination des residus alcalins des cristaux de 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one
KR950010149B1 (ko) 5-클로로-1-[1-{3-(2,3-디하이드로-2-옥소-1h-벤즈이미다졸-1-열)프로필}-4-피페리딘]-1,3-디하이드로-2h-벤즈이미다졸-2-온(돔페리돈) 액제의 제조방법
RU2199321C1 (ru) Смесевая лекарственная форма на основе фторпиримидинового антиметаболита и способ ее получения
FI72302C (fi) Foerfarande foer framstaellning av stabilt mikrokristallint cisplatin.
EP1663106A2 (fr) Composition pharmaceutique, procede de fabrication et utilisation d'une telle composition a des fins therapeutiques
RU97119749A (ru) Способ лечения рака мочевого пузыря

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: ERBAMONT INDUSTRIALE S.R.L.

DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: ERBA S.R.L. FARMITALIA CARLO -

BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed